Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer

Oncogene

Volumn 21, Issue 47, 2002, Pages 7277-7282

  Wagner, Kate J ^a   Cooper, Wendy N ^a   Grundy, Richard G ^a,b   Caldwell, Germaine ^a   Jones, Carolyn ^a   Wadey, Roy B ^a,b   Morton, Dion ^a   Schofield, Paul N ^c   Reik, Wolf ^d   Latif, Farida ^a   Maher, Eamonn R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Colorectal cancer; Methylation; RASSF1A; Wilms' tumour

Indexed keywords

PROTEIN P16;

ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 3P; COLON CANCER; DNA METHYLATION; GENE INACTIVATION; GENE LOSS; GENE SILENCING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS; DNA METHYLATION; GENES, P16; GENES, TUMOR SUPPRESSOR; GENES, WILMS TUMOR; HUMANS; KIDNEY NEOPLASMS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RNA, UNTRANSLATED; SILENCER ELEMENTS, TRANSCRIPTIONAL; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; WILMS TUMOR;

EID: 18644383745     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205922     Document Type: Article

References (34)

1. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER and Latif F. (2001). Oncogene, 20, 1509-1518.
2. Ahuja N, Li Q, Mohan AL, Baylin SB and Issa JP. (1998). Cancer Res., 58, 5489-5494.
3. Arcellana-Panlilio MY, Egeler RM, Ujack E, Pinto A, Demetrick DJ, Robbins SM and Coppes MJ. (2000). Gene Chromosome Cancer, 29, 63-69.
4. Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER and Latif F. (2001). Oncogene, 20, 7573-7577.
5. Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T and Pelletier J. (1994). Nat. Genet., 7, 91-97.
6. Baylin SB, Herman JG, Graft JR, Vertino PM and Issa JP. (1998). Adv. Cancer Res., 72, 141-196.
7. Burbee DG, Forgacs E, Zöchbauer-Müller S, Shivakumar L, Gao B, Randle D, Virmani A, Bader S, Sekido Y, Latif F, Fong K, Gazdar AF, Lerman MI, White M and Minna JD. (2001). J. Natl. Cancer Inst., 93, 691-699.
8. Costello JF and Plass C. (2001). J. Med. Genet., 38, 285-303.
9. Cui H, Horon IL, Ohlsson R, Hamilton SR and Feinberg AP. (1998). Nat. Med., 4, 1276-1280.
10. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP. (2000). Nat. Genet., 25, 315-319.
11. Davies R, Moore A, Schedl A, Bratt E, Miyahawa K, Ladomery M, Miles C, Menke A, van Heyningen V and Hastie N. (1999). Cancer Res., 59 (Suppl), S1747-S1750; discussion S1751.
12. Hao X, Willis IE, Pretlow TG, Rao JS, MacLennan GT, Talbot IC and Pretlow TR. (2000). Cancer Res., 60, 18-21.
13. Herman JG, Graft JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
14. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR and Linehan WM. (1994). Proc. Natl. Acad. Sci. USA, 91, 9700-9704.
15. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB, (1998). Proc. Natl. Acad. Sci. USA, 95, 6870-6875.
16. Issa JP, Vertino PM, Boehm CD, Newsham IF and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 11757-11762.
17. Jones PA. (1999). Trends Genet., 15, 34-37.
18. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R. (1997). Cancer Res., 57, 808-811.
19. Lee SB and Haber DA. (2001). Exp. Cell Res., 264, 74-99.
20. Lerman MI and Minna JD. (2000). Cancer Res., 60, 6116-6133.
21. Luo XN, Reddy JC, Yeyati PL, Idris AH, Hosono S, Haber DA, Licht JD and Atweh GF. (1995). Oncegene, 11, 743-750.
22. Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F and Maher ER. (2001). Cancer Res., 61, 7277-7281.
23. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, Kraus W, Gerald W and Tycko B. (1994). Nat. Genet., 7, 440-447.
24. Okamoto K, Morison IM, Taniguchi T and Reeve AE. (1997). Prec. Natl. Acad. Sci. USA, 94, 5367-5371.
25. Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA and Jones PA. (2001). Hum. Mol. Genet., 10, 903-910.
26. Richards FM, Schofield PN, Fleming S and Maher ER. (1996). Hum. Mol. Genet., 5, 639-644.
27. Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL and Feinberg AP. (1994). Nat. Genet., 7, 433-439.
28. Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M and Clark SJ. (1997). Cancer Res., 57, 2229-2237.
29. Thiagalingam S, Lisitsyn NA, Hamaguchi M, Wiglet MH, Willson JK, Markowitz SD, Leach FS, Kinzler KW and Vogelstein B. (1996). Cancer Res., 56, 2936-2939.
30. Toyota M, Ohe-Toyota M, Ahuja N and Issa JPJ. (2000). Proc. Natl. Acad. Sci. USA, 97, 710-715.
31. Tycko B. (2000). J. Clin. Invest., 105, 401-407.
32. van Engeland M, Roemen GM, Brink M, Pachen MM, Weijenberg MP, de Bruine AP, Arends JW, van den Brandt PA, de Goeij AF and Herman JG. (2002). Oncogene, 21, 3792-3795.
33. Vos MD, Ellis CA, Bell A, Bitter MJ and Clark GJ. (2000). J. Biol. Chem., 275, 35669-35672.
34. Waber PG, Chen J and Nisen PD. (1993). Cancer, 72, 3732-3738.